Pamela Vig, Chief Scientific Officer at Mirum Pharmaceuticals, Inc. (MIRM), bought 1,612 shares at $11.88 ($18K) on 2019-09-06, disclosed to the SEC on 2019-09-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.96 | 1,600 | $18K | 99.2% |
| 2 | $11.88 | 12 | $143 | 0.8% |
| Total | $10.97 avg | 1,612 | $18K | 100% |
| Filing → |
| MIRM | SELL | 2024-02-05 | $32K | — | Filing → |
| MIRM | SELL | 2024-01-09 | $39K | — | Filing → |
| MIRM | SELL | 2023-07-05 | $37K | — | Filing → |